From Todd Bensman for the Daily Wire

Maltz attributes slowing fentanyl smuggling directly to Trump’s controversial 25% trade tariffs, which compelled the first Mexican military raids against production labs in Sinaloa Cartel-controlled Culiacán, Mexico.

It’s early but not too early to note that President Donald Trump’s all-out World War on cross-border fentanyl smuggling into the United States, the highly lethal synthetic opiate responsible for 120,000 American overdose deaths in recent years, is achieving remarkable impacts for the first time in a decade.

A key indicator of broader total smuggling at and between the southern border’s ports of entry — U.S. law enforcement seizures of fentanyl — has dropped 50% since the November election, indicating a greater decline in total fentanyl smuggling.

That decline is attributable to Trump’s reset of U.S. Customs and Border Protection orders to aggressively hunt the drug as they and thousands of active-duty soldiers are now free of the distracting duty of processing hundreds of thousands of illegal immigrants crossing the southern border every month throughout Joe Biden’s term. Trump policies quickly ended that mass migration distraction, as I wrote in The Daily Wire on March 20.

A 2024 seizure of fentanyl pills manufactured in Mexico. DEA photo.

For context on the change with inbound fentanyl flows, from 2019 to 2023, the amounts seized rose every year in tandem with American overdose deaths and remained high in the 2,000-pound monthly range during 2024.

But In December and January, President-elect Trump threatened devastating trade tariffs against Mexico if they did not seriously crack down on cartel production and smuggling even before he entered office.

From October 2024 to January 2025, Southwest Border seizures of fentanyl fell from 2,000 pounds in 85 seizure events, to 990 pounds in 47 seizure events, CBP seizure data shows. Then in February 2025, seizures plummeted even further to 590 pounds in 45 events.

Combined, those January and February numbers are 50% less than the same period in 2024 and among the very lowest monthlies recorded since 2020.

City of Scottsdale, AZ, police department.

Ranking administration officials, Border Patrol supervisors who hunt the drug on the ground, and media reporting from cartel laboratory-infested regions of Mexico tell us that March’s seizure numbers will solidify a reversal of a deadly decade-long upward fentanyl smuggling trend.

“Trump’s policies are having an impact, one hundred percent,” Acting Administrator of Trump’s Drug Enforcement Administration Derek Maltz told me for this Daily Wire story. And for Americans concerned about the scourge of fentanyl, there’s much more they will find surprising.

A Remarkable Display Of Cartel Pragmatism In Response To Trump

Derek S. Maltz, U.S. Drug Enforcement Administration. Photo by Gabe Skidmore. Wikimedia Commons.

What Maltz said next almost defies commonly believed narratives about Mexico’s cartel crime syndicates — especially the idea that they are more impulsively violent than strategic and pragmatic. Yet, according to Maltz, cartel leaders appear to have opted for a surprising strategic change in the face of Trump’s campaign against them over fentanyl.

The cartels appear to have determined that since Trump is so bad for business, they have decided to quit smuggling it into the American market and send it to Europe and other parts of the world instead. What to do about the lost revenue? Easy. Make up the difference by shipping greater volumes of less-politically and physiologically lethal drugs like cocaine and methamphetamine, Maltz said.

“We got their attention with a lot of talk about the deaths in America, and the cartels got very concerned. It became a business decision.” Maltz told me.

Indeed, cartels in the fentanyl crosshairs are facing a unique, existential threat that no prior president in modern times has imposed, over just this one line of cartel business. While it’s too early for anyone to declare victory in Trump’s unprecedented war on fentanyl, Maltz attributes slowing fentanyl smuggling directly to Trump’s controversial 25% trade tariffs, which compelled the first Mexican military raids against production labs in Sinaloa Cartel-controlled Culiacán, Mexico.

After his November 2024 election win, Trump vowed to follow through with executive orders that would establish punishing tariffs on China for tolerating the export of precursor fentanyl-making chemicals to Mexico. And almost since inauguration day, Trump’s moves have compelled the destruction of laboratories.

Andrew Harnik/Getty Images

He designated nine Mexican cartels as Foreign Terrorist Organizations subject to global financial isolation, surveillance and terrorism charges for anyone who partners with them.

The cartels no doubt also felt heat from unspecified threats of possible U.S. military action against them and their labs. Indeed, Trump has increased U.S. spy flights over Mexico, repositioned CIA officers into Mexico, deployed war ships to the Pacific and Gulf of America, and put specialized light infantry divisions on the southern border facing Mexico.

An Unlikely Source Of Credit For Trump: The New York Times

As part of the Trump administration, Maltz might be expected to lose some credibility by crediting his boss’s policies for good news about fentanyl.

Maltz is hardly alone, however, in attributing Trump’s policies to early apparent success. Natalie Kitroeff, the New York Times’ Mexico City bureau chief toured some manufacturing labs in the city of Culiacán with another reporter in December 2024, the Sinaloa Cartel-controlled city believed to be Mexico’s central hub for manufacturing fentanyl with well over 100 labs.

Getty Images. View of the historic center of Culiacán, capital city of the state of Sinaloa, with the main Alvaro Obregón street that runs from north to south.

In a March 2025 interview on the newspaper’s The Daily podcast, Kitroeff said she returned to Culiacán after Trump’s inauguration “to see whether all of the pressure that Trump had put on Mexico had led to real changes, whether any of this actually made a difference.”

After serendipitously witnessing Mexican troops raiding labs as she drove through Culiacán on a follow-up trip, Kitroeff’s conclusion was clear.

“It was really remarkable. The dynamics, it seemed, had completely changed from the last time we were there,” she said, adding that her cartel sources “told us there was basically no production of fentanyl happening in the city. It had totally plummeted, fallen off a cliff” because “there is such an intense crackdown by the government right now.”

“Is this all because of Trump?” the show’s host Michael Barbaro asked Kitroeff.

“Yeah, I think that’s what it looks like to a lot of people, a lot of regular Mexicans, a lot of cartel members, and a lot of security experts who have been studying this for a long time,” she responded.

“I think it’s pretty clear that the amount of progress, arrests, raids, lab busts, the pace of these actions is something that we’ve not seen in recent history in Mexico. One analyst told us, we’ve seen in one month what we might have seen in years,” Kitroeff continued. “I think what we’ve seen is that at least in this context, in this month, and in this place, the tariffs worked, for now at least.”

The reporter and Maltz said production still goes on elsewhere in Mexico.

But Maltz said his government intelligence suggests the cartels are contemplating shipping the drug to Europe, Australia and to other wealthy developed countries but not as much to the United States because of the Trump heat.

“They’re going to produce it and ship it over that way instead,” he said. “There’s a very good chance that other parts of the world may be getting shipments of fentanyl from the cartels, unless they just curtail the production altogether, which I don’t see happening.”

He and others also note that U.S. law enforcement began seizing higher volumes of cocaine and methamphetamine smuggled over the border since Trump’s election instead of fentanyl, also suggesting a self-preserving cartel strategy change.

What About American Deaths? 

Michael Siluk/UCG/Universal Images Group via Getty Images

Another vital indicator that warrants tracking as a means to judge the long-term success of Trump’s muscular fentanyl initiatives: overdose deaths.

It’s just too early to know how the apparently falling smuggling rates translate into saved lives. Significant declines in overdose deaths began a year ago, according to the latest Center for Disease Control report on the subject, which lags real time by four months. Death rates fell by 24% for the 12 months through September 2024, from 114,000 to a still outrageous 87,000. The CDC attributes the decline to better life-saving treatment and awareness programs inside the United States but also to a factor it dubs without elaboration “shifts in the illegal drug supply.”

National Center for Health Statistics. CDC.

That factor almost assuredly is a reference to a secretive deal that President Joe Biden bartered for Mexico in December 2023 to deploy 35,000 troops with orders to militarily contain illegal immigration flows in deep southern Mexico to help Biden’s presidential reelection campaign defend its border policies against Trump. Mexico responded to Biden’s favor request with major impactful force throughout the Biden or Harris reelection campaign that dramatically reduced human smuggling, as I frequently reported, and also no doubt hindered some fentanyl smuggling.

Trump watchers and all Americans who authentically care about the extreme damage this drug from Mexico has wrought on the United States should hope seizures continue to plummet as this likely means less is getting smuggled over. But Americans deserve to know if “shifts in illegal drug supply” is saving far more American lives.

If that body count number alone continues an even faster decline, Trump will have earned his country’s enduring gratitude and a place of reverence in American history. So far, anyway, the early results give rise to optimism.

* * *

Todd Bensman is a Senior National Security Fellow, Center for Immigration Studies and a two-time National Press Club award winner. He is a graduate of the University of Missouri School of Journalism and a 23-year veteran newspaper reporter. He is the author of “America’s Covert Border War,” and “Overrun: How Joe Biden Unleashed the Greatest Border Crisis in U.S. History.”

From LifeSiteNews

By Heidi Klessig, M.D.

The Stanford researchers admit that some people may find these ideas about clones repugnant but justify them on the basis of research already in progress.

In the 2005 sci-fi thriller The Island, Scarlett Johansson and Ewan McGregor discover that they are clones, created as an “insurance policy” for wealthy people who might need them for “spare parts.” Now, scientists at Stanford are proposing that we make this dystopian fiction a reality. On March 25, 2025, Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi wrote in MIT Technology Review:

Recent advances in biotechnology now provide a pathway to producing living human bodies without the neural components that allow us to think, be aware, or feel pain. Many will find this possibility disturbing, but if researchers and policymakers can find a way to pull these technologies together, we may one day be able to create “spare” bodies, both human and nonhuman.

These researchers say that “human biological materials are an essential commodity in medicine, and persistent shortages of these materials create a major bottleneck to progress.” Using techniques reminiscent of Aldous Huxley’s Brave New World (in which fetuses destined for menial tasks are selectively poisoned to diminish their intelligence), they propose using human stem cells and artificial wombs to create human clones which they call “bodyoids.” The article describes it this way:

Such technologies, together with established genetic techniques to inhibit brain development, make it possible to envision the creation of “bodyoids”—a potentially unlimited source of human bodies, developed entirely outside of a human body from stem cells, that lack sentience or the ability to feel pain.

The researchers say that these neurologically impaired human clones could provide an almost unlimited source of organs, tissues, and cells for use in transplantation. They admit that some people may find these ideas repugnant but justify them on the basis of research already in progress. They correctly point out that we are already using neurologically injured people as research test subjects.

“Brain dead” people who are biologically alive but who have been declared legally dead are currently being used as test hosts for the implantation of genetically modified pig livers and kidneys. These brain-injured people who are being used as xenograft hosts are certainly alive (since they are stable enough to be used as test subjects for implanted animal organs) until they are killed at the end of the experiment for further anatomical and microscopic analysis. The Stanford scientists use this ethically problematic practice to justify creating human clones for research: “In all these cases, nothing was, legally, a living human being at the time it was used for research. Human bodyoids would also fall into that category.”

The scientists admit that human cloning raises ethical problems, saying that the use of bodyoids  “might diminish the human status of real people who lack consciousness or sentience.” But the article is clearly written in the spirit of the ends justifying the means. In their call for action, the authors conclude, “Caution is warranted, but so is bold vision; the opportunity is too important to ignore.”

On the contrary, the value of every human being is what is too important to ignore. We value and protect every person because they are made in the image of God, regardless of the way they were brought into the world. Using unconscious people as research subjects is wrong, both in the case of brain-injured people declared “legally dead” (under the logical fallacy of  brain death), and also with this new proposal for bioengineering human clones. Salve Regina University philosopher Dr. Peter J. Colosi explains it this way:

You, as the person who you are, exist even when you are not conscious, and this means that other human beings who are not conscious could also do that. In the branch of philosophy that I am calling Christian personalism, there have been many convincing arguments developed to show the reasonableness of the presence of a person in all classes of nonconscious or minimally conscious living human beings.

Also, it is wrong to create people with the sole purpose of using them to fulfill our own desires. Dr. Colosi makes this clear:

Furthermore, the creation of human beings with the deliberate intent to destroy some of them for the sake of others…is a clear example of what Pope Francis has referred to as “The Throw Away Culture”: The throwaway culture says, “I use you as much as I need you. When I am not interested in you anymore, or you are in my way, I throw you out.” It is especially the weakest who are treated this way — unborn children, the elderly, the needy, and the disadvantaged.”

Creating people to be used as commodities for “spare parts” is unconscionable. Do we really want to be spending our taxpayer dollars this way? Yet Stanford Medicine’s Center for Clinical and Translational Research and Education just received a $70 million NIH grant. The purpose of this grant is to “accelerate the translation of newly discovered biomedical treatments into interventions that improve patient care and population health.”

READ: The case of Zack Dunlap shows the incoherence of ‘brain death’

Rather than accelerating, we need to stop, expose, and defund these morally abhorrent attempts to purposely bioengineer neurologically impaired human clones as a source of “spare parts.” A pro-life ethic protects all human life from experimentation and abuse.

Heidi Klessig MD is a retired anesthesiologist and pain management specialist who writes and speaks on the ethics of organ harvesting and transplantation. She is the author of The Brain Death Fallacy, and her work may be found at respectforhumanlife.com.